Moreover, IGF-1 signalling is known to be dysregulated by both toxin-induced inflammation and central obesity [5, 21, 22], consistent with our model identifying prospective biomarkers predictive of greater PD risk in these categories. Here, IGF1 is linked to Parkinson disease.